Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Motor Activity 15Neoplasms 11Breast Neoplasms 11Prostatic Neoplasms 7Obesity 5Head and Neck Neoplasms 5Signs and Symptoms 3Sarcopenia 3Polycystic Ovary Syndrome 3Lung Neoplasms 3Diabetes Mellitus, Type 2 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Pharyngeal Neoplasms 2Osteoporosis, Postmenopausal 2Osteoporosis 2Lymphoma 2Leukemia 2Laryngeal Neoplasms 2Fatigue 2Diabetes Mellitus 2Weight Loss 1Uterine Neoplasms 1Urinary Incontinence 1Stroke 1Squamous Cell Carcinoma of Head and Neck 1Sedentary Behavior 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma 1

Interventions

Fluorouracil 128Leucovorin 120Oxaliplatin 101Irinotecan 89Bevacizumab 55Cetuximab 44Capecitabine 40Folfox protocol 29Panitumumab 22Colonoscopy 17Chemotherapy, Adjuvant 16Floxuridine 15Early Intervention, Educational 15Erlotinib Hydrochloride 13Surveys and Questionnaires 11IFL protocol 11Counseling 11Immunohistochemistry 10Gemcitabine 10Celecoxib 10Psychiatric Rehabilitation 9Methods 8Magnetic Resonance Spectroscopy 8Gene Expression Profiling 8Exercise 8Dexamethasone 8sargramostim 7Sorafenib 7Radiotherapy 7Nivolumab 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Colonic Neoplasms × Resistance Training × Clear all
NCT03291951 2022-07-28

FORCE

Kaiser Permanente

Phase NA Completed
183 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡